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Mechanisms of Platelet Activation and Control: Volume 344, Advances in Medicine and Biology; Edited by Kalwant S. Authi, 
Steve P. Watson and Vijay V. Kakkar,  P lenum Press, New York, 1993; xiv + 272 pages. $79.50. ISBN 0-306-44631-6. 
This book presents a compilation of review chapters emanating from 
papers presented at an International P atelet Symposium held at the 
Thrombosis Research Institute, Chelsea, London, in April 1992. Of the 
invited speakers, twelve were from Europe (including the UK), eight 
from North America and one from Japan. These speakers represent 
some of the top researchers in the world on the molecular mechanisms 
of platelet activation. 
The book succinctly summarizes the present state of knowledge in 
this rapidly advancing field for both novices and those knowledgeable 
in the area. Almost every aspect of signal transduction i platelets is 
covered, including details of thrombin agonist receptors, G proteins, 
the regulation of phosphoinositide-specific phospholipase C, the role 
of cytoskeleton i regulating platelet function, and the mechanism of 
stimulation of cyclic nucleotide-dependent pro ein kinases, as well as 
the possible role of their substrates. 
The book starts with a thoughtful and useful discussion by Dr. 
Michael C. Scrutton of the platelet as a Ca2+-driven cell. This chapter 
sets the stage for many of the other chapters in the book. One learns 
about 'direct' response patterns, such as those induced by thrombin or 
PAF, 'adhesion-dependent' pa terns as is characteristic of collagen as 
well as 'aggregation-dependent' pa terns characterized by 'feed- 
forward' amplification loops involving the synthesis of thromboxane 
A2 and the release of ADP. Not surprisingly, several of the concepts 
introduced in this chapter, such as the function of cytosolic Ca 2÷ in 
signal transduction, and the ability of factors uch as diacylglycerol, G 
proteins, cAMP, and cGMP to modulate Ca2*-driven responses, are 
returned to subsequently and in more detail by other contributors to 
the book. 
Obviously, in this brief review, it is impossible to describe (or even 
mention) each individual chapter, or give credit o each of the chapter's 
authors. But, to highlight a few: Dr. Lawrence E Brass and his co- 
authors provide an outstanding review of the recently cloned seven 
transmembrane domain thrombin receptor and of G proteins as 
mediators of platelet activation; Dr. Yoshininori Nozawa and his co- 
workers present an interesting paper on the regulation of 
phosphoinositide-specific phospholipase C in platelets; there are three 
chapters on calcium signalling in platelets; five chapters on the role of 
protein kinases and phosphatases in signal transduction (either from 
the point of view of activation or inhibition of platelet function); three 
chapters on the regulation of platelet function by the cytoskeleton, etc. 
It should be pointed out that these chapters have little overlap with each 
other, and in fact provide complementary information to the reader. 
Another topic covered in the book that is worthy of mention is the 
role of rap 113 in platelet function. Research on this subject is presented 
in three chapters in the book. This protein is present in platelets in high 
abundance and is phosphorylated onserine-179 by a cAMP-dependent 
protein kinase. Interesting arguments are given in each chapter 
regarding the significance of the phosphorylation f this protein and 
of its translocation within the platelet. However, the weight of evidence 
seems to suggest hat the phosphorylation f raplB is not related to 
inhibition of platelet responses by cAME 
In summary, this focused compilation of chapters by top scientists 
involved in understanding the molecular mechanisms of platelet 
activation and control provides outstanding reading for anyone 
interested in the area. Clearly, the field has come a long way but the 
book reveals that there is still some way to go. 
J. Bryan Smith 
From Genetics to Gene Therapy; Edited by D.S. Latchman, BIOS Scientific Publishers; Oxford, 1994; xix + 261 pages. $99.00. 
ISBN 1-872748-36-8. 
This monograph is the first in a UCL Molecular Pathology Series 
published under the auspices of the Department of Molecular 
Pathology of the University College London Medical School. The book 
is based on a December 1992 meeting, but also contains chapters 
especially commissioned for this volume. 
The rapid advancement of the application of molecular biology in the 
understanding and treatment ofhuman disease has led to the emergence 
of the field of molecular pathology. In this volume, exciting 
developments in this area "from genetics to gene therapy" are 
illustrated for individual diseases. The 13 chapters of this book, written 
by mainly British contributors, range from in-depth analysis of known 
disease genes, such as the genes for apolipoprotein B or dystrophin, 
over genes for X-linked immunodeficiency diseases, to a survey and 
assessment of more complex genetic omponents of diseases uch as 
leukaemia, breast cancer or diseases of the nervous system, 
supplemented with chapters on gene transfer methodology. Although 
the volume is not intended to cover the complete field (e.g. there is no 
separate chapter dealing with cystic fibrosis), the editor should be 
complimented for the extent o which the unifying theme of employing 
genetic knowledge towards therapy has inspired the authors. What I 
find particularly appealing is the increasing level of genetic omplexity 
through the book that indirectly may give the reader a feeling for the 
increase in understanding and therapeutic potential that further 
knowledge of the genes involved in particular diseases may bring. 
The book is not free from the heterogeneity characteristic of 
symposium publications and some of the shorter chapters erve merely 
as an introduction to the literature. However, the inclusion of chapters 
that have been timely written specifically for this monograph, elps to 
make this overall a both useful and inspiring book. 
This book may fulfill a need as an appetizer for molecular biologists 
who may wish to enter the field of molecular pathology and as a 
state-of-the-art manifestation of the power of molecular genetics for 
those working in clinical medicine. 
Finn Skou Pedersen 
Advanced Organic Chemistry of Nucleic Acids; Edited by Z. Shabarova nd A. Bogdanov, VCH; Weinheim, 1994. xv + 588 pages. 
DM 248.00. ISBN 3-527-29021-4. 
The book is a brave attempt o write the text book on nucleic acid 
organic hemistry. This is quite a formidable task in a broad and rapidly 
expanding field. 
The book is divided into 11 chapters covering: 1, Structure of 
nucleosides; 2, Properties of nucleosides; 3, Structure of nucleotides; 
4, Properties of nucleotides; 5, Primary structure of nucleic acids; 
6, Determination of the primary structure of nucleic acids; 
7, Conformation of nucleic acid components; 8, Macromolecular 
structure of DNA and RNA; 9, Chemical properties ofpolynucleotides; 
10, Catalytic activity of nucleic acid; and 11, Synthesis of nucleic acids. 
The text is a translation from Russian. Fortunately, however, it is 
only in a few places where this fact penetrates the language. 
The material is presented in a traditional way with some emphasis 
on the historical development of the chemistry, but carries through to 
include state-of-the-art p ocedures both in pure chemistry as well as in 
more molecular biology-oriented applications. 
Seen from an anglosaxon point of view, some of the material covered 
is 'Russian' in the way that the results have only to some extent 
appeared in the English literature. This is not necessarily a disadvantage 
since much very good organic hemistry, which is not yet appreciated 
in our part of the scientific society, has been done in Russia. 
I found the book a rich source of factual information on nucleic acid 
